According to a new market report by Lucintel, the future of the epigenetic market looks promising with opportunities in pharmaceutical and biotechnology industries. The epigenetic market is expected to grow with a CAGR of 13% from 2019 to 2024. The major growth drivers for this market are surge in prevalence of cancer, rising geriatric population, technological advancements in epigenetics research, and availability of government funding.
To download report brochure, please go to https://www.lucintel.com/epigenetic-market.aspx and click "report brochure" tab from the menu.
In this market, enzymes, instruments and consumables, kits, reagents, and bioinformatics tools are used to make changes to the function and/or regulation of molecules, without altering their primary sequences. Kits is the largest segment.
Within the epigenetic market, oncology is the largest application due to increasing prevalence of cancer worldwide.
North America is the largest market over the forecast period due to research activities on epigenetics by government funding, presence of advanced healthcare facilities, and continual advancements in diagnostic procedures.
Illumina, Thermo Fisher Scientific, Merck Millipore, Abcam, Active Motif, Bio-Rad, New England Biolabs, Agilent, and Qiagen are among the major manufacturers of the epigenetic market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the epigenetic market by product, application, end use industry, technology, and region. Lucintel has prepared a comprehensive research report titled "Epigenetic Market 2019-2024: Trends, Forecast, and Opportunity Analysis". This Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the epigenetic market by product, application, end use industry, technology, and region as follows:
By Product [$M shipment analysis for 2013 – 2024]:
Enzymes
Instruments and Consumables
Kits
Reagents
Bioinformatics Tools
By Application [$M shipment analysis for 2013 – 2024]:
By End Use Industry [$M shipment analysis for 2013 – 2024]:
Pharmaceutical
Biotechnology
Others
By Technology [$M shipment analysis for 2013 – 2024]:
DNA Methylation
Histone Methylation
Histone Acetylation
Large noncoding RNA
MicroRNA Modification
Chromatin structures
Others
By Region [$M shipment analysis for 2013 – 2024]:
North America
United States
Canada
Mexico
Europe
Asia Pacific
Rest of the World
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/epigenetic-market.aspx or helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.